Similarly, as already indicated above, the expression of surface PRRs is modulated in patients with COPD; TLR2, TLR4, and TLR5 are expressed at lower levels in macrophages from patients with COPD [126, 148, 236, 237]. This evidence concerns the gene TLR5 and chronic obstructive pulmonary disease.